www.worldsleaders.com Vol.

09 | Issue 01 | September 2023

Dr. Rupert Ecker

World’s Visionary

Healthcare
Entrepreneurs
to Watch in 2023

Prioritizing Diversity,
Collaboration, and
Ethical Conduct
in Advancing
Scientific Progress
 World's Visionary Healthcare
Entrepreneurs to Watch in 2023

Saviors of Tomorrow

Today's leaders in science must not only advance their

field's knowledge and technology but also diversity,
inclusion, and moral behavior. Scientific leaders are
supposed to encourage cooperation and teamwork across
various research groups, advance scientific education and
literacy, and effectively communicate with the general
public about the significance and impacts of science.

Healthcare has historically benefited greatly from strong

leadership. The importance of healthcare leadership cannot
be overstated in an environment where a tiny choice may
have a significant impact on someone's life. The greatest
healthcare services can only be delivered by strong leaders
who can coordinate staff comprehension, performance, and
requirements. Staff members and caregivers feel assured in
their jobs and responsibilities under imaginative leadership.
The attitude of the workforce is more likely to reflect the
basic principles and objectives of the firm when the
leadership is balanced.
World's Leaders latest edition “World's Visionary
Healthcare Entrepreneurs to Watch in 2023” has featured
success stories of renowned healthcare leaders from across
the world whose expertise in leadership is echoing globally.
The cover has Dr. Rupert Ecker, the CEO, co-founder, and
co-owner of TissueGnostics. He has been intrigued by
science and motivated to push beyond existing boundaries.
His aspiration of achieving scientific breakthroughs has
been fulfilled by creating pioneering technology that has
enabled researchers to broaden their understanding of cells,
tissues and organs. Furthermore, his innovative analytical
techniques have facilitated the understanding of the
molecular foundation of cancer and other ailments as well
as contributed to the development of novel therapeutic
regimen in precision medicine. Dr. Ecker, along with his
former mentor and business associate Georg Steiner,
established TissueGnostics in 2003.
Dr. Rupert, in his role as CEO of TissueGnostics GLOBAL,
is responsible for overseeing the company's strategic
direction, R&D, quality policies, and collaboration with
academic institutions. His primary passion lies in
actualizing creative ideas and translating theory into
practical applications.
Also, while you flip through the pages, don't forget to read
the articles created by our in-house editorial staff and
industry experts.
Have a lovely read!
 CREDIT PAGE

Editor-in-Chief Steve Sanchez

Managing Editor Jagdish Chincholikar
Executive Editor Nicole Williams
Assistant Editor Gayatri Bhujbal

Art & Design Director Jack Anderson

Business Development Manager Mia Oliver
Business Development Executive Natalie, Jerrey
Associate Designer Kevin Rust

Digital Marketing Manager Victor Clarke

Sales Manager Casey Simpson, Irfan Shekh
Marketing Manager Tom Swann
Technical Specialist Barry Jones
Circulation Manager Danny Parker

SEPTEMBER 2023

3296 Westerville Rd #250, Columbus, OH 43224, USA

Copyright 2023 WORLD’S LEADERS Media Tech LLC, All rights reserved. The content and images used in this magazine
should not be reproduced or transmitted in any form or by any means, electronic, mechanical,
photocopying, recording or otherwise, without prior permission from WORLD’S LEADERS Reprint rights
remain solely with WORLD’S LEADERS.

Follow us on :
Dr. Rupert
Ecker
Prioritizing Diversity,
Collaboration, and
Ethical Conduct in
Advancing Scientific
Progress

08
COVER
STORY
18 David Contorno

22 Dr. Nicole-Odom-Hardnett

28 Dr. Robi Ludwig

32 Gavin Quinnies

36 Haden A. Land

40 Kristen Poe

46 Marisa Faircloth

50 Oriol Segarra

54 Raman Singh
Dr. Rupert Ecker
08 | SEPTEMBER 2023
 Cover
Story

Prioritizing Diversity, Collaboration, and Ethical

Conduct in Advancing Scientific Progress

worldsleaders.com | 09
 L
eadership in science today involves
not only advancing scientific
knowledge and technology but also
promoting diversity, inclusivity, and
ethical conduct. Scientific leaders are
expected to foster collaboration and
teamwork among diverse groups of
researchers, promote scientific literacy
and education, and communicate
effectively with the public about the
importance and impact of scientific
research.
Dr. Rupert Ecker, the CEO, co-founder, and
co-owner of TissueGnostics, has been
intrigued by science and motivated to
push beyond existing boundaries. His
aspiration of achieving scientific
breakthroughs has been fulfilled by
creating pioneering technology that has
enabled researchers to broaden their
10 | SEPTEMBER 2023
understanding of cells, tissues and organs.
Furthermore, his innovative analytical
techniques have facilitated the
understanding of the molecular
foundation of cancer and other ailments
as well as contributed to the development
of novel therapeutic regimen in precision
medicine. Dr. Ecker, along with his former
mentor and business associate Georg
Steiner, established TissueGnostics in
2003.
Dr. Rupert, in his role as CEO of
TissueGnostics GLOBAL, is responsible for
overseeing the company's strategic
direction, R&D, quality policies, and
collaboration with academic institutions.
His primary passion lies in actualizing
creative ideas and translating theory into
practical applications.
worldsleaders.com | 11
 i c s G m b H
e G no s t
T issu
TissueGnostics (TG) is a company that
specializes in providing advanced
solutions for the analysis of tissue
samples using artificial intelligence-
empowered precision microscopy with
integrated image cytometry software.
Their solutions are used by scientists
across the biomedical research
continuum, including pathologists, who
require a deep understanding of tissue
structures at a cellular level. Pathology
is a field that involves recognizing
relevant structures and extracting
diagnostic and prognostic information
from tissue samples that may have been
stained with by various techniques, like
H&E, IHC, immunofluorescence, multi-
spectral and/or multiplexing assays.
TissueGnostics' solutions are computer-
based and provide automated
microscopy and tissue image cytometry,
12 | SEPTEMBER 2023
which require high precision and
performance. The company is
committed to remaining at the forefront
of this field and aims to provide its
solutions to every researcher and
clinician working with tissue sections
and/or cell cultures in 2D, 3D, or 4D.
While microscopy consists of a
manifold of techniques and
technologies and thus requires a
profound knowledge of those in order to
obtain feasible results, TissueGnostics
also acts as a translator by providing
high-level solutions to users who are
not experts in the field of microscopy
and/or image analysis. This is done
through their technology platform of
tissue cytometers.
worldsleaders.com | 13
Journey of Founding TG GLOBAL

Originally aspiring to become an astronomer,

Dr. Ecker eventually turned his attention to the
microcosmos and pursued a degree in cell
biology. He is a co-inventor of the TissueFAXS
technology and played a pivotal role in the
establishment of TG and its international
offices and subsidiaries, serving as CEO and
CSO of TG GLOBAL. During his post-
doctoral research position at the Kplus
Competence Centre for BioMolecular
Therapeutics, which was a joint venture
between University of Vienna and the Novartis
Research Centre, he co-founded the company.

As a student, Dr. Ecker's goal was to contribute

to scientific progress, and he found his personal
way of achieving this goal through TG. Over
the past 20 years, the company has not only
built a strong product portfolio but also made a
significant scientific impact, with over 2,500
scientific studies published in approximately
800 peer-reviewed journals that utilized TG's
technology in various ways. The scientific
applications of TG's technology range from
basic research to clinical implementation
studies, from bone marrow to brain, from cell
cultures to solid tissue sections, covering the
entire spectrum of biomedical research from A
(like Atopic dermatitis) to Z (like Zika virus
infection). Dr. Ecker is proud to have played a
part in this success story.

Collaboration and Multidisciplinary

Expertise

TissueGnostics was established by researchers

out of a need for automation and quantification
of microscopic images. Throughout its history
of 20 years, collaborative research has been
integral to the company's success.
TissueGnostics has participated in more than
20 Austrian national collaborative research
projects and has been an industry partner to
seven major EU-funded Marie Skłodowska-
Curie Innovative Training Networks (ITN) as
well as other EU programs such as COST
Actions, Framework 6/7, HORIZON 2020, and
HORIZON EUROPE programs.

14 | SEPTEMBER 2023
From Academia to
Entrepreneurship
Dr. Ecker's personal biggest risk
was leaving academia and
venturing into entrepreneurship
by founding TissueGnostics. It
was like taking a leap of faith
into unknown waters to test not
only the temperature of the
water but also his ability to
swim. However, his company
has become a leading provider
of tissue image cytometry,
offering automated analysis of
tissue samples using computer
assistance and AI-driven
technology for medical research
and histopathology.
TissueGnostics serves as a one-
stop-shop for their customers'
needs in this field.

worldsleaders.com | 15
Dr. Ecker's success in starting and
expanding TissueGnostics is attributed
to his multidisciplinary expertise in
biology, software engineering,
business, leadership, scientific
presentations, and social competence.
As an emerging leader, it is essential to
have a broad range of knowledge and
skills, but it is also important to
recognize one's limitations and build a
complimentary team.
Advancing Science Literacy,
Developing User-Friendly
Instruments, and Championing
Precision Medicine
Dr. Ecker has identified three areas that
he would like to improve in society,
MedTech, or people's lives. Firstly, he
would like to improve the general
public's understanding of science and
artificial intelligence, both in terms of
what they can do and what they cannot
do. Dr. Ecker believes that a better
understanding of these subjects could
lead to more informed decisions and
better outcomes for everyone.
Dr. Ecker is also interested in
developing instruments for research
and diagnostics that are powerful yet
easy to use. He believes that such
instruments would lower the barriers to
successful research and diagnosis and
could lead to new discoveries and
improved patient outcomes. Finally,
Dr. Ecker is passionate about precision
medicine, which seeks to provide
targeted therapies for each individual
patient, rather than for "averaged
patient cohorts." He believes that
precision medicine has the potential to
revolutionize healthcare and improve
patient outcomes, and he is committed
to advancing this field through his
work at TissueGnostics.
16 | SEPTEMBER 2023
Team Building through 'Holistic
Complementarity’
Dr. Ecker believes that it is crucial for
a company's success to have a team
with the right set of skills and
personalities. It is not enough to have
technically qualified employees; they
must also be able to work well with
others and contribute to a positive team
spirit. Therefore, when hiring new
team members, Dr. Ecker looks for a
person's "holistic complementarity" - a
combination of professional skills and
personal as well as social
qualifications. This approach may not
be practical for larger companies, but it
is a luxury and a beauty one can enjoy
as CEO of a small to medium-sized
company. In such companies, it is
possible to build a close-knit team that
works well together and is passionate
about the company's mission. This, in
turn, can lead to a more productive and
successful company.
Technology Milestones on Tissue
Image Cytometry
Dr. Ecker would attribute the most
significant changes in his career over
the past three decades to milestones in
computer technology development.
When he started out, the focus in
biomedical research was on simply
making novel research approaches
possible using technology. Later, there
was a shift towards doing things with
the help of computers. Ten years ago,
there was an emphasis on automating
research tasks, and now the expectation
seems to be on utilizing artificial
intelligence throughout any research
roadmap to the point of generation of
actual knowledge.
Future Plans in the Biomedical
Research Industry
Starting as a small company in Vienna,
Austria, TissueGnostics has now
grown into a global structure with
subsidiaries and offices located in
Europe, USA, Asia, China, South
America, Africa, and Australia.
However, despite being present on all
continents, the company is not yet
represented in all countries with
significant biomedical research
activities. With the 20th anniversary in
2023 - and beyond – TissueGnostics
plans to introduce innovative products,
expand its market presence, and extend
its global service into more territories.
One of the major challenges faced by
the company is the rapid pace of both,
technological development and market
needs, which are continuously
evolving. Unlike some of its
competitors, especially in the US,
TissueGnostics has had limited funding
opportunities during its start-up and
initial growth phases and has had to
achieve its goals through cash flow
rather than multi-million-dollar
investments. In Dr. Ecker's opinion,
TissueGnostics is like a small but
highly agile mammal in a wilderness
full of ravenous dinosaurs. The fact
that TissueGnostics celebrates its 20th
Anniversary in 2023 and that it has
expanded from a Vienna-based start-up
to a global entity over the past two
decades, proves that it requires more
than huge investments to run and grow
a company – inspiration and
dedication. This is what drives the
entire team at TG and empowers the
company's global footprint in
accordance with the corporate motto:
TissueGnostics – Precision that
Inspires.
worldsleaders.com | 17
18 | SEPTEMBER 2023
 DAVID
CONTORNO
Revolutionizing the Health Insurance Industry with
Transparent and Patient-Centric Health Plans

A Passion Unveiled
David's journey in the insurance industry began at the
age of 12, but it wasn't until he turned 17 that he found his
passion in benefits and health insurance. For the first 18 years
years, he dedicated his career to providing traditional broker
services and offering conventional health plans. But inevitably,
costs went up and benefits went down. So he chose to take a
very different path. Alongside his insurance work, David also
nurtured a love for photography, which led him to pursue a
college education in the field. He even gained experience by
working at a renowned chain of camera stores, although
the company has unfortunately closed its doors since
then. Despite his detour into photography, David's
professional path has predominantly remained rooted in
the same industry he thrives in today for nearly 30 years.

worldsleaders.com | 19
I n the competitive world of insurance, few leaders have
made as significant an impact as David Contorno,
Founder & CEO of E Powered Benefits. Renowned for
his outspoken critique of traditional insurance carriers and
their detrimental effects on employers, clinicians, and
patients, David has emerged as a pioneering figure within
the industry.
Drawing from his extensive experience as a seasoned
agency owner and successful consultant, David recognized
the pressing need for change. Fueled by a passion for
transparency and a desire to empower employers, he
embarked on a groundbreaking journey to establish an anti-
BUCAH (Blues, United, Cigna, Aetna, and Humana)
brokerage. With an unwavering focus on reshaping health
plans, David aimed to re-establish control in employers'
hands while prioritizing affordable, high-quality care for all
covered patients.
David's trailblazing efforts have not gone unnoticed.
Garnering accolades and recognition, he has been honored
as Forbes' Most Innovative Insurance Broker, BenefitsPro's
Broker of the Year, and Validation Institutes' Advisor of the
Year. Furthermore, his tireless work in reforming the US
healthcare system has earned him a place in multiple New
York Times Best Selling books.
Beyond his impressive accolades, David actively engages
with audiences nationwide, spreading his wealth of
knowledge and expertise. Passionate about educating fellow
advisors and industry stakeholders, he dedicates himself to
equipping them with the tools and insights required to
deliver high-performance health plans to employers across
the country.
Empowering Employers and Employees
E Powered Benefits specializes in providing consulting
services to employers and industry brokers/consultants. The
company introduces a ground-breaking approach to
constructing a unique type of health plan that achieves what
may appear impossible but is actually remarkably simple.
Its aim is to create a health plan for employees that
significantly reduces costs for employers by 40-60%
compared to traditional plans, while offering members the
benefit of NO OUT-OF-POCKET expenses for most
services. Moreover, its plan incentivizes improved clinical
outcomes and enhances overall quality of life.
At E Powered Benefits, the company offers comprehensive
educational resources, including a validated course
accredited by The Validation Institute. Additionally, its
annual conference attracts a diverse audience of 450 or
more brokers, plan partners, and doctors, serving as a
platform for collaboration with like-minded individuals and
organizations within the industry. It actively engages with
those who are already implementing similar plans or
20 | SEPTEMBER 2023
express a desire to do so in the near future, recognizing that
progress in its field benefits all stakeholders.
While E Powered Benefits does provide a full benefits
package, its primary focus and unique selling proposition
lie in revolutionizing the most crucial aspect of employment
decisions: the health plan.
Teaching and Leading by Example
David believes that teaching is a crucial element in
achieving his goals. He actively engages in teaching and
mentoring endeavors, which have proven to be highly
rewarding. By sharing his knowledge and experiences,
David often receives significant returns on his investment.
He focuses on mentoring consultants individually, instructs
the CHVA course developed by his partner Emma Fox, and
frequently speaks in educational settings.
Furthermore, David believes in practicing what he preaches
when it comes to healthcare consumption. He applies the
same metrics and principles that he advises his clients to
use when making healthcare decisions for himself and his
family. It is essential to him that people recognize his
commitment to action rather than mere words. David
acknowledges that the industry is filled with rhetoric and
empty promises. For instance, when a Third-Party
Administrator approaches him, claiming to support the
same ideals, he challenges them by asking if they are
familiar with the tagline from the Capital One commercial,
"What's in your wallet?" If they produce a carrier ID card,
he interprets it as a sign that they do not believe in
practicing what they advocate, suggesting a double
standard.
Through his teaching, mentoring, and personal example,
David strives to bring about a shift in the industry, where
consistency and integrity in applying healthcare metrics and
incentives become the norm.
A Profit-Driven Model for True Health
David is passionate about reshaping the healthcare system
to move away from a profit-driven model that primarily
benefits when individuals are sick. He acknowledges the
existence of for-profit healthcare systems and recognizes
that even non-profit systems are motivated by profit, as
evidenced by high executive compensation and tax
exemptions, which ultimately burdens the community with
higher taxes.
However, David doesn't advocate for eliminating the for-
profit aspect of healthcare entirely. Instead, he envisions a
system where profit is maximized through keeping people
healthy. In the environment of the last few decades, at least,
if our society were to achieve true health, every healthcare
system and insurance carrier would go out of business. His
goal is to establish a society where everyone can access
quality and affordable healthcare without fear of financial
ruin. By creating such a standard, people would be relieved of
the added stress of healthcare costs, allowing them to focus
solely on dealing with the physical toll of illness, which is
already challenging enough.
David points out that the United States currently faces some
of the worst clinical outcomes among industrialized nations,
while also experiencing significantly higher healthcare costs.
The scale of these costs is often so substantial that charts
specifically tailored to the US are required when comparing it
to other top-ranking countries.
Redefining Healthcare for Positive Outcomes
David's greatest professional risk was making the decision to
stop selling traditional healthcare plans. Instead, he chose to
tie his compensation to effectively reducing costs—a
departure from the common practice where brokers and
consultants are rewarded when their clients' expenses rise.
Additionally, he committed to actively participating in the
care and well-being of each member on every plan they
service.
This shift in approach has yielded positive outcomes both
clinically and financially. By actively engaging in members'
healthcare, David's company has achieved improved clinical
outcomes while simultaneously saving employers substantial
amounts of money. Furthermore, they have gone the extra
mile by waiving all member out-of-pocket costs, ensuring that
individuals can access the necessary care without worrying
about financial burdens that may jeopardize their basic needs,
such as housing and food.
By taking these risks and embracing a new model, David has
been able to create a system that prioritizes positive health
outcomes, cost reduction, and the overall well-being of the
individuals they serve.
Building a Community
David's vision is focused on domestic expansion rather than
global reach. He aspires to build a community of consultants,
employers, and employees/patients who will challenge the
flaws within the healthcare system, which is both detrimental
and exorbitantly expensive. His goal is to create incentives for
healthcare providers to prioritize better clinical outcomes,
complete price transparency, and genuine honesty. David
urges every business owner and patient to apply the same
metrics, incentives, and intelligence they employ when
making other purchasing decisions.
He highlights the lack of price knowledge in the healthcare
industry, which is unlike any other consumer market. In
healthcare, both the end users and the service providers are
Driving Change
As the Founder and CEO, David's
responsibilities encompass speaking
engagements, sales activities, and
teaching endeavors. He frequently receives
invitations to contribute to publications,
write articles, and deliver public speeches.
The most rewarding part of his day is when
he has conversations with Americans,
especially business owners, and witnesses
the moment they grasp the backwardness
of our healthcare system compared to
other sectors of the economy.
David believes that the healthcare system
isn't broken; it's working exactly as it was
designed, but it doesn't prioritize the
needs of employers, doctors, and
patients—the key stakeholders. He has a
talent for simplifying complex healthcare
concepts into understandable stories,
helping people realize the flaws in our
current approach to healthcare and health
insurance. His goal is to inspire a shift in
thinking and create a society where
everyone has access to quality, affordable
healthcare without the fear of financial
hardship.
often unaware of the costs involved until after the fact.
This lack of transparency is a significant issue that David
aims to address. He believes that everyone should have
access to information regarding the price of healthcare
services, just as they do with any other product or service.
Additionally, he emphasizes the need for individuals to
invest time and effort into researching and evaluating their
healthcare providers, as they would when making other
important purchases, such as a vacuum cleaner on
Amazon.
worldsleaders.com | 21
 Dr. Nicole
Odom-Hardnett
Resolving Addiction Challenges with the Core Value of Helping Others

Keep moving forward, and if you can see it

“ in your mind’s eye, “you can achieve it!

22 | SEPTEMBER 2023
worldsleaders.com | 23
24 | SEPTEMBER 2023
People with addiction are often
blamed for their condition, and
society may view them as weak,
immoral, or lacking willpower. This
stigma can prevent individuals from
seeking treatment, as they may fear
being judged, ostracized, or
discriminated against. Overcoming
the stigma related to addiction care is
crucial to creating a more
compassionate and effective
approach to addiction treatment and
supporting individuals in their
recovery journeys.
Nicole Odom-Hardnett is the founder
of Focus Point Behavioral Health, a
company that provides a wide range
of behavioral health services to all
age groups. Starting with a
transitional home care company, she
followed a natural path to launching
her present chain of Behavioral
Health Centers. Throughout her
career, she faced numerous
challenges that tested her resilience,
but she remained steadfastly focused,
recognizing the importance of doing
so in her line of work.
As the visionary behind the business,
Nicole is responsible for instilling a
culture of service and dedication
throughout the company. With a
background in business, she ensures
that Focus Point operates effectively
and efficiently. Nicole is particularly
passionate about reducing the stigma
associated with addiction therapy and
“Don’t give up on
your dreams”.
mental health treatment, and she
strives to create welcoming
environments for clients in every
center. She places great emphasis on
ensuring that each center is
aesthetically pleasing and
comfortable for clients to use.
The Leap of Faith
Despite logging in over 60 hours a
week and driving countless miles in
pursuit of someone else's vision and
dream, Nicole eventually realized the
true cost of her sacrifices. It was then
that she made the decision to take a
leap of faith and build her own vision
and dream: Focus Point Behavioral
Health. Pouring all of her resources,
ideas, and faith into her new
endeavor, Nicole never looked back.
Taking that leap of faith was
undoubtedly one of the best personal
and business decisions she ever
made.
The moment that sparked Nicole's
passion for her business was when a
client left her speechless. Nicole was
thrilled to have placed this client in a
job at one of the city's largest
hospitals, knowing it would be a
significant turning point for the client
and her family. The client was
intelligent, engaging, and completed
tasks assigned to her with impressive
efficiency. However, Nicole was
shocked when the client's drug
screening returned positive for
cocaine. She was heartbroken when
she had to inform the client that the
opportunity had been lost, and the
client admitted to struggling with
cocaine addiction.
As an addiction treatment center,
Focus Point Behavioral Health aims
to address one of the biggest
challenges that Nicole observed in
her professional career prior to
starting the business. She noticed that
addiction was a significant obstacle
for many of her welfare-to-work
clients.
Nicole believes that it is fair to
conclude that addiction was the
common factor that hindered many
of her welfare-to-work clients from
achieving their job placement goals.
Her experience with these clients led
her to become a change-maker in the
way addiction is treated, supported,
and the stigma around it removed.
The Journey to Achieving Dreams
Nicole's overall value system was
molded by her upbringing in a career
military family, where "service and
dedication" were key principles. She
began her professional career by
directing and managing welfare-to-
work programs, in which she
excelled. The lessons she learned
from this experience became the
foundation for her later success as an
entrepreneur.
worldsleaders.com | 25
28 | SEPTEMBER 2023
worldsleaders.com | 29
30 | SEPTEMBER 2023
worldsleaders.com | 31
32 | SEPTEMBER 2023
worldsleaders.com | 33
34 | SEPTEMBER 2023
worldsleaders.com | 35
36 | SEPTEMBER 2023
Haden A.
Land A Tech Proficient with
Diverse Exper se in
Na onal Security and
Related Industries

worldsleaders.com | 37
 W
With a professional experience
spanning over four decades, Haden
Land possesses a diverse range of
expertise that caters to the
requirements of businesses and
government agencies working in
national security and related
industries, as well as beyond. As both
the CEO and CTO of S2P, Haden's
responsibilities are comprehensive,
covering all aspects of the business,
from start to finish. These
responsibilities are similar to those
held by the CEO and CTO of a startup
software company.

Haden takes great pleasure in

witnessing successful business
execution outcomes from optimizing
and establishing processes, people,
and technology in all essential
aspects of S2P's business operations.
He also relishes coaching and
mentoring people within the
enterprise, collaborating with
strategic partners, and engaging with
customers.

38 | SEPTEMBER 2023
Previous Work Journey
Prior to joining S2P, Land held the
position of President at his Cyber
Security and IT Senior Executive
Consulting firm and previously
served as the Vice President (VP) of
Research and Technology at
Lockheed Martin. In this role, he was
responsible for technical solutions,
strategic partnerships, global
innovation centers, research and
development, and emerging
technology planning. Before that, he
occupied various executive-level
positions at Lockheed Martin, such
as Engineering VP, R&D VP, CTO,
and CIO. In these roles, he was
accountable for devising and
implementing enterprise-wide
solutions for key customers,
including the Department of Defense,
civilian agencies, the Ministry of
Defense, USG Corporation, Fluor
Corporation, and General Motors, as
well as point solutions across other
domains. Land has also worked for
previous employers such as IBM and
Loral.
Haden Land has held several
leadership positions in the past,
which include serving as the Capitol
Technology University Board
Chairman, Prince George's
Community College Foundation
Board Chairman, Hispanic
Information Technology Executive
Council Board Director, Potsdam
University Board Trustee, Syracuse
University Engineering & Computer
Science College Dean's Leadership
Council member, Cyber Maryland
Advisory Board Member,
Washington DC CIO Executive
Committee Chair, and World
Economic Forum Member. He is a
lifetime member of the Upsilon Pi
Epsilon and Epsilon Delta Pi Honor
Societies and an Emeritus Trustee
Chair at Capitol Technology
University.
Land holds a bachelor's degree in
Mathematics and Computer Science
from Potsdam University and a
master's degree in Computer Science
from Syracuse University. He has
been honored with two honorary
degrees, a Doctor of Science from
Potsdam University and a Doctor of
Humane Letters from Capitol
College.
Haden Land has received several
accolades for his contributions to the
business and technology industry,
including being selected eight times
as one of the Top Hispanics in
Business and Technology by HE&IT
magazine, being named a Most
Influential Hispanic three times by
HITEC, and receiving the prestigious
Global CIO Executive Top 10
Breakaway Leader award from
EVANTA. He was also honored with
the Minera Lifetime Achievement
Award from Potsdam University.
Land has extensive expertise in
various technological areas such as
cloud computing, big data, cyber
security, enterprise mobility, complex
adaptive systems, engineering, IT
assessments, R&D, enterprise
architecture, business continuity/DR.
Furthermore, he has domain
knowledge within several industries,
including government, space, energy,
law enforcement, transportation,
financial, and healthcare.
Best Risk Management Offerings
S2P is a company that specializes in
healthcare and infectious-disease
risk-management solutions. Their
innovative offerings are designed to
keep people safe and organizations
productive by preventing, mitigating,
and controlling the spread of
infectious diseases. They provide
comprehensive and advanced data-
driven, intelligence-driven infectious
disease safety programs to
businesses, government agencies,
schools, and healthcare providers.
The main objective of S2P is to
empower their clients by protecting
their employees and families from
infectious diseases, avoiding
lockdowns, maintaining productivity
by preventing loss of work hours,
and demonstrating their clients' focus
on workplace health risk
management. By doing so, S2P helps
their clients prevent disease
outbreaks and minimize their impact,
enabling them to operate effectively
and safely in today's challenging
environment.
Former US FDA Principal Deputy
Commissioner and COO and former
Harvard faculty member Dr. John
Norris, JD, MBA, founded S2P for
the express purpose of preventing
deaths and other harms to workers
and their families from infectious
diseases, such as COVID-19 and its
variants.
worldsleaders.com | 39
 Owner & CEO
POE Holistic Health

40 | SEPTEMBER 2023
Kristen
Poe
Making an Impact on the World by
Providing Healthcare to Others

worldsleaders.com | 41
42 | SEPTEMBER 2023
 T
The greatest gift we can give ourselves is our
health, and almost everything else in life
depends on it. Healthcare transforms into a
collaborative, patient-centered practice that
prioritizes healing and prevention over
symptom repression. Instead of only treating
symptoms and searching for band-aid
solutions, functional health takes a systems-
based approach to addressing the
underlying causes of chronic disease and
barriers to wellness. Good nutrition and
lifestyle medicine may support and improve
almost every illness or symptom that exists.
It's not necessary for everyone to have the
agility of a tightrope walker or the stamina of
a competitive cyclist. You decide what level
of functional health you require to lead a
more fulfilling life. Meet, Kristen Poe, owner
and CEO of POE Holistic Health, who thinks
the world would benefit from more
functional health providers and modalities to
keep up with the growing demand for
functional healthcare and lifestyle medicine.

worldsleaders.com | 43
 Marisa
Faircloth
The Master Injector
Extraordinaire Leading
the Aesthetics Revolution

46 | SEPTEMBER 2023
worldsleaders.com | 47
 I
In the ever-evolving realm of medical
aesthetics, one name stands out as a true
trailblazer – Marisa Faircloth. As the Founder
and Owner of Restoration MedSpa, she has
carved an illustrious path, establishing herself
Finding Fulfillment
in Balance

Marisa handles a demanding

schedule, treating up to 30
patients daily while
simultaneously overseeing the
spa's management and
as a Master Level Injector and attaining the marketing. Despite these
prestigious Top 250 Status with Allergan.
With an impressive educational background as a responsibilities, she dedicates
graduate of Wake Forest University's esteemed
Bowman Gray School of Medicine's Physician
significant time outside of work
Assistant Program, Marisa possesses a wealth hours to enhance her business
of knowledge and experience. Her passion for
the field is evident in her more than four and fulfills her training duties.
decades of dedicated service, spanning medical Managing such a balancing act
aesthetics, plastic surgery, and weight loss.
Marisa Faircloth's unparalleled expertise in the may seem challenging, but
art of injecting has made her a sought-after Marisa successfully maintains
authority in the industry. Her mastery goes
beyond mere technical skill; she possesses a equilibrium, ensuring she also
unique artistic vision, seamlessly combining has quality time for her family,
medical science with an aesthetic eye. Patients
from all walks of life trust her discerning hands church, and indulging in her hot
to enhance their natural beauty and restore their
confidence.
tub. When reflecting on her daily
routine, Marisa finds immense
Experience Luxury and Transformation
happiness in treating her
Restoration MedSpa offers a comprehensive patients and boosting their self-
range of services in a luxurious concierge
environment, catering to all medical spa needs. confidence. She values personal
Its extensive offerings encompass various connections with each individual,
treatments, including injectables like Botox and
fillers, cutting-edge laser procedures, body taking the time to discuss their
sculpting, sexual wellness treatments, lifting
threads, and aesthetic services. Marisa and her
daily lives, and feels grateful for
team at Restoration MedSpa constantly seek out their trust in confiding their
the latest and most effective non-invasive
procedures, ensuring that they stay at the personal matters to her.
forefront of technological advancements in the
field.

48 | SEPTEMBER 2023
worldsleaders.com | 49
ORIOL
SEGARRA
Leading the Transformation of The Family Firm from
a Traditional Pharmaceutical Company to a Successful
Transnational Corporation Focused on Natural
Consumer Healthcare

It's a transformation that we are very

proud of, by the way. It's been an
extraordinary journey in which I've had
the best years of my professional life, like
many others who are part of this great
family. And we still have a lot of
challenges ahead of us!"

50 | SEPTEMBER 2023
 CEO | Uriach

worldsleaders.com | 51
 P
industry, in addition to other more
operational aspects such as
omnichannel, the growth of e-
commerce, personalization,
distribution, regulatory issues,
sustainability, direct consumer
relationships, and so on.

Oriol Segarra is a leadership and

change management expert with over
20 years of business experience in
multinational pharmaceutical firms.
As Uriach's Chief Executive Officer,
People want to live longer, but they
he oversaw the pharmaceutical
also want to live better, with
company's development from a
improved health, well-being, and
traditional pharmaceutical company
quality of life. And they understand beneficial influence on people's
to a successful transnational
that achieving this requires a health and lives while also striving to
corporation focus on natural
multifaceted approach that includes improve the earth as a whole. It
consumer healthcare.
diet, physical activity, sport, rest, provides the greatest natural goods to
sleep, body care, emotions, mind, consumers, based on sound research
Uriach is a corporation that thinks
and spirit. and creativity.
that harnessing the power of nature is
the best (and most sustainable)
This humanization and integration of With a history of over 182 years,
approach to caring for human health
many disciplines around well-being Uriach's notable worldwide
and well-being. This is why Uriach is
is undoubtedly the most significant trademarks include Aquilea,
solely dedicated to natural consumer
challenge confronting the healthcare Fisiocrem, Laborest, Aerored, Fave
healthcare. Its purpose is to have a
de Fuca, Utabon, Biodramina, and
Halibut, with a presence in the major
European markets. The company's
headquarters are presently located in
Spain, Portugal, Italy, Germany,
Austria, Switzerland, and Romania.

Life Outside of the Workplace

Oriol was born in Barcelona in 1971

and is the father of two children.
Oriol defines himself as an
inquisitive, restless, and ambitious
individual who is always looking for
new reasons, challenges, and
learning opportunities in order to
improve professionally and
personally. He attended ESADE,
Harvard, Stanford, Singularity
University, and IMD, among other
business institutions.
52 | SEPTEMBER 2023
worldsleaders.com | 53
 Raman
Singh Delivering Novel Therapies
to Improve the Health and
Quality of Life of
patients everywhere

54 | SEPTEMBER 2023
T
he previous few years have compelled leadership
techniques to modify and adapt, especially as the
pandemic pushed for mandatory work from home
policies. Numerous organizational structures and
hierarchies have also been questioned, along with
traditional leadership styles. As a result, working standards and
values have had to change as well, and to be a persuasive leader,
you must adapt in response to your environment. Leaders have had
to adapt and make their organizations or environments more
inclusive in order to be effective in our present work environment.
This has probably led to many firms functioning better than they
ever have.

Raman Singh, the founder and CEO of Juniper Biologics, has

extensive knowledge in the pharmaceutical and healthcare sectors.
He formerly served as CEO of Mundipharma, a large global
pharmaceutical firm with a focus on research. Additionally, he led
initiatives in research and development to look at how consumer
goods may assist nations in halting the COVID-19 virus’s rapid
growth. To demonstrate that certain Betadine medications (part of
the Mundipharma portfolio) might kill the COVID-19 virus in 15 and
30 seconds, laboratory testing was started at Duke-NUS and other
labs across the world. Raman was motivated to create Juniper
Biologics after working in various places and observing the
disparities in healthcare as well as the effects his work had on a
worldwide scale. His mission is to make innovative medications
available to those most in need.

worldsleaders.com | 55
 “We want to be the first to
commercialise and create
access to much needed
treatments to improve the
quality of life of patients
everywhere.”

56 | SEPTEMBER 2023
Steeping in Entrepreneurship
Raman realized the impact his work
may have on people's health on a
worldwide scale after working on the
research and development projects to
stop the spread of COVID-19. That is
what motivated him to look for novel
treatments that might prolong the
lives of patients with crippling
diseases like cancer. Raman's focus
on enhancing access to important and
inexpensive medications as well as
offering cutting-edge treatments to
improve patients' quality of life was
necessary, even though creating a
successful firm is difficult. He
observes that large pharmaceutical
corporations frequently prioritize
treating millions of patients over
treating a few hundred or thousand
people suffering from a rare
condition. He knew this is where
Juniper Biologics could make a
profound impact, because everyone
deserves access to treatments to
improve the quality of their lives.
Previous experience has also taught
Raman that hard work and resilience
will enable him to create an
organization that has significant
value. He knew that a strong
foundation of ESG values takes
Juniper Biologics to the next level,
which would ultimately allow him to
bring innovative medicines to people.
The Company
Juniper Biologics is a science-led
specialty healthcare company
focused on commercializing novel
therapies. Founded in 2021 and
globally headquartered in Singapore,
our mission is to make a real impact
on the lives of patients by improving
accessibility to the next generation of
treatments. It brings innovative
medical treatments to patients around
the world in the areas of oncology
and oncology supportive care, rare
and orphan diseases, and gene
therapy.
The company takes care to
participate in as many pertinent
industry events as it can, as both a
sponsor and an exhibitor, in order to
keep ahead of the competition.
Additionally, Juniper Biologics
makes a point of networking with as
many key figures in the scientific and
medical fields as it can. The business
is a Platinum Sponsor of the next
European Society for Medical
Oncology (ESMO) in Singapore as
well as the 2023 International Breast
Congress in Singapore. It also
sponsored the Excellence in
Oncology Care conference in Dubai.
This demonstrates its dedication and
solidifies its position as a respectable
business in the sector.
In the therapeutic areas it has chosen,
Juniper Biologics is always doing
research and looking for the most
cutting-edge therapies. Raman states,
“We want to be the first to
commercialise and create access to
much needed treatments to improve
the quality of life of patients
everywhere.”
Changing the Pharma Industry
from Within
Juniper Biologics has accomplished
significant milestones since its
inception in 2021. The license rights
to create and market TG-C LD, the
first cell-mediated gene therapy in
the world for the treatment of knee
osteoarthritis, were recently acquired
for up to USD $600 million. An
estimated 300 million patients in
Asia Pacific, the Middle East, and
Africa will be able to get this
medicine thanks to this initiative. In
addition, Juniper Biologics
completed six license agreements in
the last year and added Aloxi,
Akynzeo, and Anamorelin to its
portfolio of cancer supportive care
products, a market with a significant
unmet need worldwide.
In addition, Juniper Biologics will
shortly introduce Ledaga, a topical
gel medication for treating MF-
CTCL, the most prevalent cutaneous
T-cell lymphoma. It has secured the
licensing and marketing
authorizations to promote and sell it
in Australia, Southeast Asia, and the
Middle East. These acquisitions and
treatments are invaluable to patients
who suffer from these diseases.
A Leader's Way and His Vision
As the CEO of Juniper Biologics, it
is Raman's responsibility to move the
company's growth of Juniper
Biologics in the right direction – one
that is sustainable, innovative, and
stays true to the company's mission
and ESG values. He is in charge of
making sure that the teams in each of
the important markets for the firm are
connected, appreciated, and still
concentrating on the unmet medical
requirements of patients and the best
ways to aid them. Making calls and
checking in with his staff all across
the world is another aspect of
Raman's daily schedule that makes
him the happiest. A big part of what
Raman does is not just about the task
but also about the people.
worldsleaders.com | 57